News

Partnership aims to advance development of novel immune checkpoint therapies as Baxalta expands oncology leadership in orphan diseases.

Acquisitions provide Capsugel with specialized clinical trial manufacturing and supply capabilities.

Takeda and Enterome have announced they have entered into a strategic drug discovery collaboration to research and develop potential new therapeutics directed at microbiome targets thought to play crucial roles in gastrointestinal disorders, including inflammatory bowel diseases (e.g. ulcerative colitis) and motility disorders (e.g. irritable bowel syndrome).

Complix to receive upfront fees, research funding, and milestone payments.

An interdisciplinary research team at Illinois has developed a new material composite derived from quantum dots.

Conference to be held in UK from 26th-27th January 2016.

For the first time, scientists pin down the structure of toxic clumps of a protein associated with a large number of ALS cases, opening new avenues in the pursuit of drugs to stem the disease.

Rhythm and Camurus have announced a license agreement for the use of Camurus’ drug delivery technology, FluidCrystal®, to formulate setmelanotide (RM-493), Rhythm’s novel melanocortin-4 receptor (MC4R) agonist.

Mutation rate of Ebola virus could prove a useful therapy.

Findings also show how an experimental monoclonal antibody treatment inhibits growth and spread of cancer.